CompoAtlas

GLUCOSAMINCHONDROITINMSMVITAMINC

Food supplement declared in France, decision dated 1 May 2026

GLUCOSAMINCHONDROITINMSMVITAMINC (DrDaxiong) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Chlorhydrate de glucosamine. None of the rules we check flags an issue with its declared composition.

Brand
DrDaxiong
Food business operator placing the product on the market
Shenzhen Liweiyang Technology Co., Ltd.
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Autre : Capsule
Daily dose
2grain

Declaration 363794, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Other active ingredients

NamePer day
Chlorhydrate de glucosaminenot declared

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Brand : DrDaxiong

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “GLUCOSAMINCHONDROITINMSMVITAMINC (DrDaxiong): composition and regulation”, https://compoatlas.com/en/supplements/products/363794-glucosaminchondroitinmsmvitaminc, updated 15 November 2026.

Enter to analyse, Shift+Enter for a new line